By AuntMinnie.com staff writers

May 26, 2005 -- Healthcare technology venture development firm Research Corporation Technologies (RCT) has selected Shaun Kirkpatrick as its president and chief executive officer.

Kirkpatrick succeeds current CEO Gary Munsinger, Ph.D., who is also chairman of the RCT board of directors.

The Tucson, AZ-based company has played an early role in the commercial success of the anticancer drugs cisplatin and carboplatin, the prostate-specific antigen (PSA) blood test for prostate cancer, and technetium-99-based imaging agents.

By AuntMinnie.com staff writers
May 26, 2005

Copyright © 2005 AuntMinnie.com

 

To read this and get access to all of the exclusive content on AuntMinnie.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnie.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: